May 8, 2021
Business News

Sengenics Bolsters Leadership Team with Two New Appointments


LONDON–()–Sengenics, the Functional Proteomics Company, today announced the appointment of Daniel Tan as Chief Financial Officer and Mark D. Quigley as Vice President of Global Sales and Marketing. This announcement comes as Sengenics sees continued growth with the planned establishment of a research facility in Massachusetts, USA.

Daniel Tan is a highly accomplished Chief Financial Officer having worked senior roles for more than 25 years in audit, corporate finance, strategy and commercial finance at Baker Tilly and Barclays Bank in the UK, amongst others. Daniel has led a number of IPO assignments on the London Stock Exchange and AIM as well as due diligence engagements on mergers and acquisitions. In his…



Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Cyberattack forces Colonial Pipeline to shut major fuel line – NBC News
Article feature image
CDC may roll out seasonal Covid-19 boosters to protect against variants – CNN
Article feature image
Copper Just Smashed Past a Record. Here’s What You Need to Know